This activity was originally broadcast live at the 2022 Asembia Specialty Pharmacy Summit.
This activity features a Patient Perspective.
Program Description
Chronic rhinosinusitis with nasal polyps (CRSwNP) is an upper airway disease that can cause nasal obstruction leading to reduced sense of smell, nasal discharge, and sleep disturbances in afflicted patients. Symptoms of CRSwNP can overlap with other respiratory conditions, and pharmacists need to keep in mind the potential for patients to have comorbid conditions, such as asthma. Treatment options for CRSwNP are limited and do not address the underlying cause of disease; therefore, the need for repeated systemic prescriptions and medical interventions is necessary for many patients, contributing to significant economic burden. As integral members of the health care team, pharmacists can assist in assessing and monitoring symptom severity of patients with CRSwNP and can provide additional treatment recommendations with emerging agents. Clinical trial data supporting the use of biologic therapy for the management of CRSwNP will be examined. Expert faulty will also discuss considerations for pharmacists to promote medication access barriers some patients with CRSwNP may encounter and its effects on adherence to treatment and solutions to improve patient outcomes. This activity features a Patient Perspective interview where a patient with CRSwNP shares their story that will provide pharmacists with additional insight into treatment and management of patients with CRSwNP.
Target audience: Managed care pharmacists and specialty pharmacists
Type of activity: Application
Release date: May 10, 2022
Expiration date: May 10, 2023
Time to complete activity: 1.5 hours
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Investigate the epidemiology, pathophysiology, risk factors, disease trajectory, burden of disease, and quality of life implications of chronic rhinosinusitis with nasal polyps (CRSwNP)
- Classify current treatment guidelines and paradigms of care for the management of CRSwNP
- Examine safety and efficacy data, mechanism of action, and the role of biologic therapy for the management of CRSwNP
- Illustrate the role of the pharmacist in optimizing the management of patients with CRSwNP through identification, patient education, shared decision making, and monitoring for appropriate use of medications
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
